|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ISRCTN |
|
Last refreshed on:
|
19 February 2018 |
|
Main ID: |
ISRCTN66157730 |
|
Date of registration:
|
13/06/2006 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with teRutroban in patients with a history oF ischaemic strOke or tRansient ischaeMic attack
|
|
Scientific title:
|
Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with teRutroban in patients with a history oF ischaemic strOke or tRansient ischaeMic attack |
|
Date of first enrolment:
|
22/02/2006 |
|
Target sample size:
|
18000 |
|
Recruitment status: |
Completed |
|
URL:
|
http://isrctn.com/ISRCTN66157730 |
|
Study type:
|
Interventional |
|
Study design:
|
Randomized double-blind parallel-group study (Treatment)
|
|
Phase:
|
Not Applicable
|
|
|
Countries of recruitment
|
|
Austria
|
Belgium
|
Bulgaria
|
Canada
|
Chile
|
China
|
Croatia
|
Czech Republic
|
|
Finland
|
France
|
Greece
|
Hong Kong
|
India
|
Ireland
|
Korea, South
|
Lithuania
|
|
Mexico
|
Morocco
|
Netherlands
|
New Zealand
|
Norway
|
Portugal
|
Romania
|
Singapore
|
|
Slovenia
|
Sweden
|
Taiwan
|
Tunisia
|
Ukraine
| | | |
|
Contacts
|
|
Name:
|
Marie-Germaine
Bousser |
|
Address:
|
Hopital Lariboisiere
Service de Neurologie
2 Rue Ambroise Pare
75010
Paris
France |
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
|
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Male or female aged at least 55 years with recent history of stroke or transient ischaemic attack
Exclusion criteria: Haemorrhagic stroke
Age minimum:
Age maximum:
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
Ischaemic stroke
Circulatory System
Ischaemic stroke
|
|
Intervention(s)
|
|
S 18886 (terutroban) versus antithrombotic agent
|
|
Primary Outcome(s)
|
|
Cerebrovascular and cardiovascular events
|
|
Secondary Outcome(s)
|
|
Safety criteria
|
|
Secondary ID(s)
|
|
2005-003700-10
|
|
CL3-18886-012
|
|
Source(s) of Monetary Support
|
|
Institut de Recherches Internationales Servier (France)
|
|
Ethics review
|
Status:
Approval date:
Contact:
First Ethics Committee approval in Italia on 06/12/2005, reference number: 42
|
|
Results
|
|
Results available:
|
Yes |
|
Date Posted:
|
|
|
Date Completed:
|
31/03/2010 |
|
URL:
|
|
|
|